Sands Capital Ventures’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Sands Capital Ventures's RGEN Position: Q4 2022 in Review
Sands Capital Ventures sold out of Repligen (RGEN) in Q4 2022, closing a stake of 22,544 shares — an estimated $4.22M sold.
Sands Capital Ventures first reported a position in RGEN in Q3 2021 and held it in 5 quarters. The position peaked at $6.51M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q4 2022.
- Sands Capital Ventures reported no remaining Repligen position as of Q4 2022 after selling out during the quarter.
- Sands Capital Ventures sold 22,544 Repligen shares in Q4 2022, an estimated $4.22M.
- Sands Capital Ventures first reported a position in Repligen in Q3 2021 and held it in 5 quarters.
- Sands Capital Ventures's Repligen position peaked at $6.51M in Q3 2021.
- 441 funds tracked by Wall St. Rank held Repligen as of Q4 2022.
Based on Sands Capital Ventures's 13F filing for Q4 2022, filed 13 Feb 2023.